NDC 70518-1390

Lantus Solostar

Insulin Glargine

Lantus Solostar is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Glargine.

Product ID70518-1390_74e97848-7c78-aae7-e053-2991aa0a1ac4
NDC70518-1390
Product TypeHuman Prescription Drug
Proprietary NameLantus Solostar
Generic NameInsulin Glargine
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2018-08-28
Marketing CategoryNDA / NDA
Application NumberNDA021081
Labeler NameREMEDYREPACK INC.
Substance NameINSULIN GLARGINE
Active Ingredient Strength100 [iU]/mL
Pharm ClassesInsulin [Chemical/Ingredient],Insulin Analog [EPC]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 70518-1390-0

5 SYRINGE in 1 PACKAGE (70518-1390-0) > 3 mL in 1 SYRINGE
Marketing Start Date2018-08-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-1390-0 [70518139000]

Lantus Solostar INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA021081
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-28
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
INSULIN GLARGINE100 [iU]/mL

OpenFDA Data

SPL SET ID:3e2d9cf8-0952-4361-8e87-cd5c380ad485
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 847230
  • 847232
  • PHarm Class EPC
  • Insulin Analog [EPC]
  • NUI Code
  • N0000175453
  • N0000004931
  • Pharmacological Class

    • Insulin [Chemical/Ingredient]
    • Insulin Analog [EPC]

    NDC Crossover Matching brand name "Lantus Solostar" or generic name "Insulin Glargine"

    NDCBrand NameGeneric Name
    0088-2219Lantus Solostarinsulin glargine
    70518-1390Lantus SolostarLantus Solostar
    0088-5020Lantus SolostarLantus Solostar
    50090-1398Lantus SolostarLantus Solostar
    0002-7715BASAGLARInsulin glargine
    0002-8214BASAGLARInsulin glargine
    0088-2220Lantusinsulin glargine
    0024-5869TOUJEOinsulin glargine
    0024-5871TOUJEO Maxinsulin glargine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.